Effect of DHEA on Skin Aging in Postmenopausal Women

CHU de Quebec-Universite Laval150 enrolled

Overview

The purpose of the study is to determine the response of skin parameters related to skin aging to the local action of DHEA in postmenopausal women.

Humans, along with the others primates, are unique among animal species in having adrenals that secrete large amounts of the inactive precursor steroids dehydroepiandrosterone(DHEA)and especially its sulfate DHEA-S. The marked reduction in the formation of DHEA-S by the adrenals during aging results in a dramatic fall in the formation of androgens and estrogens in peripheral target tissues, a situation that has been proposed to be associated with age-related diseases including skin atrophy, insulin resistance and obesity. Moreover, much attention has been given to the benefits of DHEA administered to postmenopausal women, especially on the bone, skin, vagina and well being after oral as well as percutaneous administration of the precursor steroid. Therefore this study proposes to study the effect of 0.3% DHEA cream during a period of 12 months administered twice daily to postmenopausal women. During the study several biological and clinical parameters will be evaluated. In summary, these include blood steroid levels, distribution of hormonal receptors in the skin, sebaceous gland activity, skin hydration, skin wrinkles and finally skin genomic evaluation. Subjects will be evaluated at specific time intervals for the above mentioned parameters as well as tolerability and adverse reactions.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

150

Conditions

Skin Aging Quality of Life

Interventions

DehydroepiandrosteroneDRUG

3.0 ml of 0.3% DHEA cream applied on the skin twice daily.

PlacebosDRUG

3.0 ml of placebo cream applied on the skin twice daily.

Eligibility

Sex: FEMALEMin age: 60 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy postmenopausal women who have taken hormonal replacement therapy for at least two years but not during the last 6 months prior to the study. * Aged between 60 and 65. Exclusion Criteria: * Significant dermatologic, metabolic and endocrine disease. * Diagnosis of cancer or history of hormone-dependant cancer. * Over exposure to sun or tanning session during the previous two months. * Narcotic addiction, alcoholism or smoking.

Locations (1)

Clinique des Traitements Hormonaux- CHUL Research Center

Sainte-Foy, Quebec, Canada

Outcomes

Primary Outcomes

Determination of local activity of DHEA for a 12 months period in parameters such as wrinkles, sebaceous gland activity, changes in skin morphology and other physical skin parameters.

Secondary Outcomes

Evaluation of tolerance to local skin application of DHEA for a 12 months period and potential beneficial effects on quality of life including sexual life.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.